Last reviewed · How we verify
NCT03441035
Albumin Mass Balance in Liver Transplantation
trial testing General anesthesia and surgery (liver transplantation) in Liver Transplant; Complications in 200 participants. Status unknown.
28 February 2021
Quick facts
| Lead sponsor | Ake Norberg |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 27 March 2018 |
| Primary completion | 28 February 2021 |
| Estimated completion | 30 June 2021 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- General anesthesia and surgery (liver transplantation)
Conditions studied
- Liver Transplant; Complications — all drugs for Liver Transplant; Complications →
- Fluid Overload — all drugs for Fluid Overload →
Sponsor
Ake Norberg
Who can join
Eligibility, any sex, with Liver Transplant; Complications or Fluid Overload. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical observational cohort study assess the loss of albumin from blood circulation during and after liver transplantation by mass balance of albumin. The overall assumption of this method is that if albumin is more diluted than hemoglobin, it must have left the plasma, presumably into the interstitial space. Predictors of albumin leakage will be assessed, including biomarkers of inflammation and of endothelial damage and dysfunction. The sub cohorts children and patients with complications, defined as prolonged postoperative treatment in the intensive care unit, respectively, will be focused in separate publications.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03441035
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Liver Transplant; Complications
Currently open trials in the same condition.
- NCT06257407 — Perioperative Hemostasis Management in Liver Transplantation · recruiting
- NCT06533592 — The Effect of the Type of Conduit-duct Anastomosis Technique on the Postoperative Course in Patients Undergoing Liver Tr · NA · recruiting
- NCT06400771 — Safety of DNP007 in Healthy Subjects · Phase 1 · recruiting
- NCT06386198 — HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients · NA · recruiting
- NCT06236568 — Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation · NA · recruiting
Other Ake Norberg trials
Trials by the same sponsor.
- NCT05956015 — Albumin Catabolic Rate Measured by a Stable Isotope · NA · not yet recruiting
- NCT01686776 — A Prospective Validation Study of Albumin Kinetics With Tracer 123 I-HSA · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03441035 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ake Norberg
- Last refreshed: 3 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03441035.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing